Sarah Remmer Long

Sarah Remmer Long

Partner, New York
Sarah Remmer Long
Sarah Remmer Long

Sarah Remmer Long

Partner, New York
Sarah Remmer Long

Biography

Sarah Remmer Long is a partner our global Employment, Compensation & Benefits practice based in New York.

Sarah advises corporate clients and senior executives on executive compensation, employment and benefits matters arising in mergers and acquisitions, dispositions, financings, securities offerings, restructurings and other complex corporate transactions. She helps clients navigate the compensation and governance issues that are often among the most sensitive and business-critical aspects of a transaction.

Sarah guides clients throughout the transaction lifecycle, balancing the technical requirements of compensation, tax and securities laws with commercial considerations, governance objectives and stakeholder concerns. Her experience spans a broad range of industries and transaction types, including sophisticated cross-border matters.

Sarah regularly counsels public and private companies on the design, implementation and administration of executive compensation and incentive arrangements, including equity and cash incentive plans, deferred compensation programs, retention arrangements, employment agreements and separation arrangements.

Sarah also counsels boards of directors, compensation committees and executive management teams on executive compensation disclosure, securities law compliance, stock exchange requirements and related corporate governance matters.

Prior to joining White & Case, Sarah was special counsel in the executive compensation practice at another international law firm.

Experience

Representative matters include: 

  • Intrepid Financial Partners in its pending acquisition by Houlihan Lokey.
  • Merck KGaA in its $11.3 billion pending acquisition of Bio-Techne Corporation.
  • Cenlar Capital in the $172.5 million pending acquisition of its subservicing business by PennyMac Financial Services.
  • U.S. Bancorp in its $1 billion pending acquisition of BTIG.
  • Central Bancompany in its $373 million IPO and Nasdaq listing.
  • CBRE Group in its $1.2 billion acquisition of Pearce Services from New Mountain Capital.
  • Jack in the Box in its $115 million sale of Del Taco Holdings to Yadav Enterprises.
  • Fifth Third Bancorp in its $10.9 billion acquisition of Comerica Incorporated.
  • SmartBiz in its acquisition of United Community Bancshares and its wholly-owned subsidiary, Centrust Bank.
  • Merck in its $3.9 billion acquisition of SpringWorks Therapeutics.
  • Guild Holdings Company in connection with Bayview Asset Management's $1.3 billion acquisition of all the outstanding shares of Guild that it did not already own.
  • Masimo Corporation in its $350 million sale of its Sound United consumer audio business to HARMAN International.
  • Discover in its $50.6 billion merger with Capital One.
  • Canadian Pacific Kansas City ("CPKC") in its and Lanco Group/Mi-Jack's sale of the Panama Canal Railway Company, a 50/50 joint venture between CPKC and Lanco Group/Mi-Jack, to APM Terminals.
  • The Otto Bremer Trust, a majority shareholder of Bremer Financial Corporation, in connection with Bremer Financial Corporation's approximately $1.4 billion merger with Old National Bancorp.
  • Tien Tzuo, Chairman, Founder & CEO of Zuora, in its $1.7 billion acquisition by Silver Lake Partners and in Mr. Tzuo's rollover and governance and employment arrangements.
  • First Busey Corporation, the holding company for Busey Bank, in its $916.8 million merger with CrossFirst Bankshares, the holding company for CrossFirst Bank, pursuant to which CrossFirst merged with and into Busey.
  • CBRE Group in its acquisition of Direct Line Global from Guardian Capital.
  • AXA Investment Managers in its acquisition of W Capital Management.
  • Alumina, as U.S. counsel, in its $2.2 billion acquisition by Alcoa.
  • Allianz X, an investment arm of Allianz SE, in its $450 million strategic investment in AlTi Global, alongside Constellation Wealth Capital.
  • Ginkgo Bioworks in its acquisition of substantially all of Zymergen's intellectual property assets and certain other assets in connection with Zymergen's bankruptcy proceedings.
  • Seagen in its $43 billion acquisition by Pfizer.
  • SVB Financial Group in the sale of its investment banking business, SVB Securities, to a management team bidder group led by Jeff Leerink, SVB Securities' Chief Executive Officer and Founder, and backed by funds managed by The Baupost Group and in its acquisition of Leerink Holdings, the parent company of Leerink Partners.
  • FGS Global in its investment by KKR.
  • Credit Suisse in its $3.3 billion merger with UBS.
  • Biohaven in its $11.6 billion sale to Pfizer.
  • UnitedHealth Group in its equity purchase agreement and related agreements relating to the sale of ClaimsXten to TPG Capital for $2.2 billion, and in Optum's $13.8 billion acquisition of Change Healthcare.
  • Collectors, the parent company of PSA, in raising $100 million in new funding at a $4.3 billion valuation, its acquisitions of Card Ladder and SGC, and in a series of transactions with eBay that include a commercial agreement, the sale of Goldin from Collectors to eBay, and the sale of the eBay vault from eBay to PSA.
  • Cornerstone Building Brands in its $5.8 billion acquisition by Clayton, Dubilier & Rice, $500 million sale of its coil coatings business to BlueScope Steel and $245 million acquisition of Cascade Windows.
  • Signify in its $272 million acquisition of ams OSRAM's Fluence horticulture lighting systems business and brand, and $1.4 billion acquisition of Cooper Lighting Solutions from Eaton.
  • Mitsubishi UFJ Financial Group in its $8 billion sale of MUFG Union Bank to U.S. Bancorp.
  • Canadian Pacific Railway in its $31 billion acquisition of Kansas City Southern, which created the first rail network connecting the U.S., Mexico and Canada.
  • Knoll in its $1.8 billion acquisition by Herman Miller.
  • Ontario Teachers' Pension Plan in its strategic investment in Mitratech.
  • Wells Fargo & Company in its $750 million sale of its Corporate Trust Services (CTS) business to Computershare.
  • K+S Aktiengesellschaft in its $3.2 billion sale of its Americas salt business to Stone Canyon Industries Holdings, Mark Demetree and affiliates.
  • The AZEK Company in its $879.5 million IPO.
  • Cronos Group in its agreement with Kristen Bell in the launch of Happy Dance™, a line of Premium CBD Skincare and its $300 million acquisition of four of Redwood Holding Group's operating subsidiaries.
  • Novartis in its $9.7 billion acquisition of The Medicines Company.
  • Fiserv in its $22 billion acquisition of First Data Corporation.
  • Piper Sandler in its merger with Sandler O'Neill.
  • Royal Philips in its acquisition of the Healthcare Information Systems business of Carestream Health.
  • Motivate, the operator of CitiBikes and the largest bikeshare operator in North America, in its acquisition by Lyft.
  • Andeavor in its $35.6 billion acquisition by Marathon Petroleum and $6.4 billion acquisition of Western Refining.
  • First Hawaiian Bank in its $555.7 million IPO.
  • Navistar International in its $3.7 billion acquisition by TRATON (formerly Volkswagen Truck & Bus) and strategic alliance with TRATON.
  • FirstMerit Corporation in its $3.4 billion merger with Huntington Bancshares.

*Certain matters prior to joining White & Case.

New York
JD
Boston University School of Law
BA
Bucknell University
English

Service areas